Marc Lopez

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 5

Top Venues

Nature communications

Molecular cancer therapeutics

Cells

This page only lists publications with an associated author ORCID identifier.

Publications

Olivier Cabaud, Ludovic Berger, Emerence Crompot, José Adélaide, Pascal Finetti, Sèverine Garnier, Arnaud Guille, Nadine Carbuccia, Anne Farina, Emilie Agavnian, Max Chaffanet, Anthony Goncalves, Emmanuelle Charafe-Jauffret, Emilie Mamessier, Daniel Birnbaum, François Bertucci, Marc Lopez
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate. Molecular cancer therapeutics 21 (7) (2022)
Maroua Manai, Ines ELBini-Dhouib, Pascal Finetti, Haifa Bichiou, Giancarlo Feliciello, Dorra Aissaoui, Naziha Ben-Hamida, Emilie Agavnian, Najet Srairi-Abid, Marc Lopez, Fatma Amri, Lamia Guizani-Tabbane, Khaled Rahal, Karima Mrad, Mohamed Manai, Daniel Birnbaum, Emilie Mamessier, Massimo Cristofanilli, Hamouda Boussen, Maher Kharrat, Raoudha Doghri, François Bertucci
MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer. Cells 11 (18) (2022)
Bernadette de Rauglaudre, Pascal Finetti, David Jérémie Birnbaum, Marc Lopez, François Bertucci, Emilie Mamessier
First-in-Human, Phase I Study of PCA062 in Solid Tumors-Letter. Molecular cancer therapeutics 21 (11) (2022)
Racha Fayad, Monserrat Vázquez Rojas, Mariagrazia Partisani, Pascal Finetti, Shiraz Dib, Sophie Abelanet, Virginie Virolle, Anne Farina, Olivier Cabaud, Marc Lopez, Daniel Birnbaum, François Bertucci, Michel Franco, Frédéric Luton
EFA6B regulates a stop signal for collective invasion in breast cancer. Nature communications 12 (1) (2021)
Tania M Puvirajesinghe, François Bertucci, Ashish Jain, Pierluigi Scerbo, Edwige Belotti, Stéphane Audebert, Michael Sebbagh, Marc Lopez, Andreas Brech, Pascal Finetti, Emmanuelle Charafe-Jauffret, Max Chaffanet, Rémy Castellano, Audrey Restouin, Sylvie Marchetto, Yves Collette, Anthony Gonçalvès, Ian Macara, Daniel Birnbaum, Laurent Kodjabachian, Terje Johansen, Jean-Paul Borg
Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer. Nature communications 7 (2016)

Marc Lopez.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marc Lopez